Comparative effectiveness of tenofovir in treatment-naïve HIV-infected patients: systematic review and meta-analysis-Reference-Cited by-同舟云学术

Comparative effectiveness of tenofovir in treatment-naïve HIV-infected patients: systematic review and meta-analysis

Published:2015-09-23 Issue:5 Volume:16 Page:178-189
ISSN:1528-4336
Container-title:HIV Clinical Trials
language:en
Short-container-title:HIV Clinical Trials

Author:

Hemkens Lars G.,Ewald Hannah,Santini-Oliveira Marilia,Bühler Julian-Emanuel,Vuichard Danielle,Schandelmaier Stefan,Stöckle Marcel,Briel Matthias,Bucher Heiner C.

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases

Link

http://www.tandfonline.com/doi/pdf/10.1179/1945577115Y.0000000004

Reference58 articles.

1. Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment

2. Atazanavir Plus Ritonavir or Efavirenz as Part of a 3-Drug Regimen for Initial Treatment of HIV-1

3. Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interaction between antiretroviral therapy regimens and body mass index on triglyceride levels in people living with HIV: a cross-sectional and longitudinal study;Lipids in Health and Disease;2024-07-30

2. Distinct patterns of fasting plasma glucose and lipid profile levels over time in adults tested positive for HIV on HAART in Shanghai, China, revealed using growth mixture models;Frontiers in Medicine;2023-01-17

3. Effectors of Hyperlipidemia Among Patients with HIV/AIDS Taking Second-line Antiretroviral Therapy Based on Registry Data;Current HIV Research;2022-09

4. Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living with HIV: Lipid Changes and Statin Underutilization;Clinical Drug Investigation;2021-09-21

5. Risk of chronic kidney disease in people living with HIV by tenofovir disoproxil fumarate (TDF) use and baseline D:A:D chronic kidney disease risk score;HIV Medicine;2020-11-28